G. Pohl-Boskamp GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:G. Pohl-Boskamp GmbH & Co KG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11148
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
G. Pohl-Boskamp GmbH & Co KG (Pohl-Boskamp) is a developer of medicines and medical devices. The company offers products which include GeloMyrtol forte, GeloRevoice, GeloSitin Nasenpflege, GeloSitin Nasal Care, GeloBronchial-Saft, GeloDurat-Salbe, GeloDuratInhalator N, Laxopol, Nitrolingual akut Spray and Nitrolingualforte, among others. Its products are used in the therapeutic areas of respiratory system, parasites, urinary tract, cardiovascular system and gastrointestinal tract. The company markets its products through a network of distributors in the UK, the US, China, the Netherlands, Canada and Australia. Pohl-Boskamp is headquartered in Hohenlockstedt, Germany.

G. Pohl-Boskamp GmbH & Co KG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Espero Pharma Raises Funds through Seed Financing 10
Partnerships 11
Navamedic Enters into Agreement with G. Pohl-Boskamp 11
Licensing Agreements 12
Espero Pharma Enters into Licensing Agreement with G. Pohl-Boskamp 12
Espero Pharma Enters into Licensing Agreement with Pohl-Boskamp 13
G. Pohl-Boskamp GmbH & Co KG – Key Competitors 14
G. Pohl-Boskamp GmbH & Co KG – Key Employees 15
G. Pohl-Boskamp GmbH & Co KG – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
Mar 03, 2017: Myrtol 300 Introduces Respiratory Health Supplement at Natural Products Expo West 2017 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Key Facts 2
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
G. Pohl-Boskamp GmbH & Co KG, Deals By Therapy Area, 2012 to YTD 2018 8
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Espero Pharma Raises Funds through Seed Financing 10
Navamedic Enters into Agreement with G. Pohl-Boskamp 11
Espero Pharma Enters into Licensing Agreement with G. Pohl-Boskamp 12
Espero Pharma Enters into Licensing Agreement with Pohl-Boskamp 13
G. Pohl-Boskamp GmbH & Co KG, Key Competitors 14
G. Pohl-Boskamp GmbH & Co KG, Key Employees 15

List of Figures
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
G. Pohl-Boskamp GmbH & Co KG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[G. Pohl-Boskamp GmbH & Co KG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intellect Design Arena Limited:戦略・SWOT・企業財務分析
    Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report Summary Intellect Design Arena Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • La Francaise Des Jeux SA:企業の戦略的SWOT分析
    La Francaise Des Jeux SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Elron Electronic Industries Ltd (ELRNF)-医療機器分野:企業M&A・提携分析
    Summary Elron Electronic Industries Ltd (Elron), a subsidiary of IDB Holding Corp Ltd is a holding company that offers medical devices and technology solutions. The company offers patient care systems for stroke care, microbiology, age-related macular degeneration, orthopedics, and heart diseases. I …
  • Illinois Tool Works Inc.:企業のM&A・事業提携・投資動向
    Illinois Tool Works Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Illinois Tool Works Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • ION Geophysical Corp (IO):石油・ガス:M&Aディール及び事業提携情報
    Summary ION Geophysical Corp (ION) is a provider of seismic solutions. It offers geoscience products, services and solutions to the global oil and gas industry. The company acquires, process and interpret data from seismic surveys in regional data programs, which become part of the multi-client data …
  • Ascletis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ascletis Inc (Ascletis) is a healthcare company that provides therapeutics for cancer and infectious diseases. The company offers discovery, demonstration of global partnering, clinical proof-of-concept, and research and development services of novel therapeutics for life-threatening disease …
  • Vitol Holding BV:企業の戦略的SWOT分析
    Vitol Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Insightra Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Insightra Medical Inc (Insightra Medical), a subsidiary of GPB Life Science Holdings LLC is a medical device company that develops disposable devices. The company provides cardiovascular and surgical solutions. It offers cardiovascular solutions such as Ultra 7FR IAB and modulare. The Modula …
  • Agfa-Gevaert N.V.:戦略・SWOT・企業財務分析
    Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report Summary Agfa-Gevaert N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • PG&E Corp:企業の発電所・SWOT分析2018
    PG&E Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Phillips-Medisize LLC:企業の戦略的SWOT分析
    Phillips-Medisize LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hexcel Corp (HXL):企業の財務・戦略的SWOT分析
    Hexcel Corp (HXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PHC Corp:医療機器:M&Aディール及び事業提携情報
    Summary PHC Corp (PHC), formerly Panasonic Healthcare Co Ltd, a subsidiary of PHC Holdings Corp, is a medical device company that provides vitro diagnostics, medical IT and life science equipment. The company provides biomedical systems such as preservation systems, incubation systems, sterilization …
  • CBS Corporation:企業の戦略・SWOT・財務情報
    CBS Corporation - Strategy, SWOT and Corporate Finance Report Summary CBS Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Lockheed Martin Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Lockheed Martin Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • ArmaGen Inc-製薬・医療分野:企業M&A・提携分析
    Summary ArmaGen Inc (ArmaGen), formerly ArmaGen Technologies Inc is a healthcare solution provide that discovers and develops novel therapies for the treatment of neurological disorders. The company's pipeline portfolio includes AGT-181, AGT-182, AGT-183 and AGT-184 which are used for the treatment …
  • Marquette Capital Partners LLC:企業の戦略・SWOT・財務情報
    Marquette Capital Partners LLC - Strategy, SWOT and Corporate Finance Report Summary Marquette Capital Partners LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Protagonist Therapeutics Inc (PTGX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protagonist Therapeutics Inc (Protagonist) is a clinical-stage biopharmaceutical company that discovers and develops orally stable peptides as targeted therapies. The company through its proprietary technology platform develops structurally novel oral or injectable peptides for protein-prote …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆